Skip to main content
Therma Bright Inc. logo

Therma Bright Inc. — Investor Relations & Filings

Ticker · THRM ISIN · CA8834262070 LEI · 529900PN7P0GSORO2174 TSXV Manufacturing
Open in API
Filings indexed 238 across all filing types
Latest filing 2026-04-01 Regulatory Filings
Country CA Canada
Listing TSXV THRM

About Therma Bright Inc.

https://www.thermabright.com/

Therma Bright Inc. is a medical technology company that develops, acquires, and markets proprietary diagnostic and medical device technologies for the consumer and institutional healthcare sectors. The company's portfolio addresses key areas including pain management, circulation, diagnostics, and critical care. Core products and development projects include Venowave, a medical device designed to boost circulation and prevent blood clots; the Digital Cough Test (DCT), an AI-powered application developed with AI4LYF for rapid, non-invasive detection of respiratory diseases; and the PREVA™ clot retriever, developed with Inretio for enhanced thrombectomy procedures in ischemic stroke treatment. Furthermore, Therma Bright is advancing inhaled statin therapy in partnership with InVixa for the treatment of COVID-19 pneumonia and Acute Respiratory Distress Syndrome (ARDS).

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 “Certification of Interim Filings” by the CFO, covering review and fair presentation of the interim financial statements and MD&A for the period ended January 31, 2026. It is a regulatory certification form under NI 52-109, not the actual interim report itself. It does not present financial data or MD&A, but provides the officer’s certification. Hence, it does not fit “Interim / Quarterly Report” (IR) or “Report Publication Announcement” (RPA) – it is a regulatory filing form. The appropriate fallback classification is Regulatory Filings (RNS).
2026-04-01 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 0% confidence The document is a Form 52-109FV2 “Certification of Interim Filings” by the CEO, which is a regulatory compliance certificate attached to the interim financial statements and MD&A but is not itself the full interim report. It does not present the financial statements or MD&A content, nor is it an announcement of a report’s publication. It therefore does not fit the Interim/Quarterly Report (IR) category (which requires the full report), nor any other specific category. It is essentially a regulatory filing form, so the appropriate fallback classification is Regulatory Filings (RNS).
2026-04-01 English
Interim MD&A - English.pdf
Management Reports Classification · 1% confidence The document is titled “Management’s Discussion & Analysis – Quarterly Highlights” for the three and six months ended January 31, 2026. It is an interim MD&A providing management’s detailed explanation of the financial results, business trends, outlook, liquidity, and forward-looking statements for a period shorter than a year. It does not include full audited annual figures or just a brief earnings headline, but rather an in-depth narrative by management. This matches the definition of a Management Report (MDA).
2026-04-01 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Condensed Interim Consolidated Financial Statements' for the three and six months ended January 31, 2026. It contains comprehensive financial statements (Statement of Financial Position, Statement of Loss and Comprehensive Loss, Statement of Cash Flows, and Statement of Changes in Shareholders' Equity) along with detailed notes to the financial statements. This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data for a period shorter than a full fiscal year. H1 2026
2026-04-01 English
Material change report - English.pdf
Regulatory Filings Classification · 1% confidence The document is a FORM 51-102F3 Material Change Report filed under NI 51-102, disclosing the signing of a new strategic customer. It is a regulatory disclosure rather than an earnings release, capital raise, or management report. It does not fit any specialized category, so it falls into the fallback “Regulatory Filings” category (RNS).
2026-03-31 English
Material change report - English.pdf
Regulatory Filings Classification · 1% confidence The document is a Canadian Form 51-102F3 “Material Change Report,” summarizing and attaching a news release on SEDAR; it is a mandatory regulatory filing under National Instrument 51-102 and does not present financial results, governance rules, or other specialized content. It falls into the fallback “Regulatory Filings” category.
2026-03-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.